Important It is possible that the main title of the report Cone Dystrophy is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
retinal cone degeneration
retinal cone dystrophy
progressive cone dystrophy
stationary cone dystrophy
Cone dystrophy is a general term used to describe a group of rare eye disorders that affect the cone cells of the retina. Cone dystrophy can variably cause a variety of symptoms including decreased visual clarity (acuity) when looking straight ahead (central vision), a reduced ability to see colors and an increased sensitivity to light (photophobia). Cone dystrophy may be broken down into two broad groups - stationary and progressive. In stationary cone dystrophy symptoms tend to remain stable and are usually present at birth or early childhood. In progressive cone dystrophy symptoms slowly become worse over time. There are several different forms of cone dystrophy. The age of onset, progression and severity of cone dystrophy can vary greatly from one person to another, even among individuals with the same type of cone dystrophy. Some forms of cone dystrophy are inherited; other forms appear to occur spontaneously for no apparent reason (sporadically).
A variety of different and confusing names have been used to describe the various forms of cone dystrophy. Some researchers limit the term "cone dystrophy" to the progressive forms of the disorder. Other researchers use cone dystrophy as an umbrella term for both the stationary and progressive forms of cone dystrophy - examples of which include achromatopsia, incomplete achromatopsia, blue cone monochromatism, and X-linked progressive cone dystrophy. This report is a general overview report on stationary and progressive cone dystrophy. For more information on an individual form of cone dystrophy use the disorder's specific name as your search term in the Rare Disease Database or contact one of the organizations listed in the resources section of this report.
Foundation Fighting Blindness 7168 Columbia Gateway Drive, Suite 100 Columbia, MD 21046 Tel: (410)423-0600 Fax: (410)872-0574 Tel: (800)683-5555 TDD: (800)683-5551 Email: info@FightBlindness.org Internet: http://www.blindness.org/
Lighthouse International 111 E 59th St New York, NY 10022-1202 Tel: (800)829-0500 Email: email@example.com Internet: http://www.lighthouse.org
National Association for Parents of Children with Visual Impairments (NAPVI) P.O. Box 317 Watertown, MA 02272-0317 Tel: (617)972-7441 Fax: (617)972-7444 Tel: (800)562-6265 Email: firstname.lastname@example.org Internet: http://www.napvi.org
National Federation of the Blind 200 East Wells Street at Jernigan Place Baltimore, MD 21230 USA Tel: (410)659-9314 Fax: (410)685-5653 Email: email@example.com Internet: http://www.nfb.org
American Foundation for the Blind 2 Penn Plaza Suite 1102 New York, NY 10121 Tel: (212)502-7600 Fax: (888)545-8331 Tel: (800)232-5463 TDD: (212)502-7662 Email: firstname.lastname@example.org Internet: http://www.afb.org
NIH/National Eye Institute 31 Center Dr MSC 2510 Bethesda, MD 20892-2510 United States Tel: (301)496-5248 Fax: (301)402-1065 Email: email@example.com Internet: http://www.nei.nih.gov/
MD Support - The Eyes of the Macular Degeneration Community 3600 Blue Ridge Blvd Grandview, MO 64030 USA Tel: (816)761-7080 Fax: (816)761-7080 Email: firstname.lastname@example.org Internet: http://www.mdsupport.org
Genetic and Rare Diseases (GARD) Information Center PO Box 8126 Gaithersburg, MD 20898-8126 Tel: (301)251-4925 Fax: (301)251-4911 Tel: (888)205-2311 TDD: (888)205-3223 Internet: http://rarediseases.info.nih.gov/GARD/
This is an abstract of a report from the National Organization for Rare Disorders (NORD). A copy of the complete report can be downloaded free from the NORD website for registered users. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational therapies (if available), and references from medical literature. For a full-text version of this topic, go to www.rarediseases.org and click on Rare Disease Database under "Rare Disease Information".
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email email@example.com
Last Updated: 2/17/2010 Copyright 1991, 1999, 2007, 2010 National Organization for Rare Disorders, Inc.
How this information was developed to help you make better health decisions.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.